Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity [v2; ref status: indexed, http://f1000r.es/536]
Objective: To review the mechanisms of anti-cancer activity of nelfinavir and other protease inhibitors (PIs) based on evidences reported in the published literature. Methods: We extensively reviewed the literature concerning nelfinavir (NFV) as an off target anti-cancer drug and other PIs. A classi...
Main Author: | Tomas Koltai |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2015-03-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/4-9/v2 |
Similar Items
-
Commercial antibodies and their validation [v1; ref status: indexed, http://f1000r.es/43b]
by: JLA Voskuil
Published: (2014-10-01) -
Commercial antibodies and their validation [v2; ref status: indexed, http://f1000r.es/4jp]
by: JLA Voskuil
Published: (2014-10-01) -
Clinical applications of microRNAs [v3; ref status: indexed, http://f1000r.es/218]
by: Per Hydbring, et al.
Published: (2013-10-01) -
Clinical applications of microRNAs [v1; ref status: indexed, http://f1000r.es/14d]
by: Per Hydbring, et al.
Published: (2013-06-01) -
Nanotechnology-supported THz medical imaging [v1; ref status: indexed, http://f1000r.es/ws]
by: Andreas Stylianou, et al.
Published: (2013-03-01)